Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-13

Clinical Trial Update: TGF-(Beta) and Susceptibility to RSV

View source ↗

Summary

The NIEHS-sponsored clinical trial examined whether Transforming Growth Factor-beta influences susceptibility to respiratory syncytial virus in individuals with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Environmental Health Sciences (NIEHS) | Conditions: Asthma | Status: COMPLETED